These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 6266068

  • 1. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L, Tijhuis D, Wessels H, Haanen C.
    Thromb Haemost; 1981 Apr 30; 45(2):142-5. PubMed ID: 6266068
    [Abstract] [Full Text] [Related]

  • 2. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL.
    J Pharmacol Exp Ther; 1990 Dec 30; 255(3):1021-6. PubMed ID: 2175792
    [Abstract] [Full Text] [Related]

  • 3. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov 30; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 4. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
    Defreyn G, Gachet C, Savi P, Driot F, Cazenave JP, Maffrand JP.
    Thromb Haemost; 1991 Feb 12; 65(2):186-90. PubMed ID: 2053105
    [Abstract] [Full Text] [Related]

  • 5. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M, Endo T, Kanayama T, Hidaka H.
    J Pharmacol Exp Ther; 1984 Feb 12; 228(2):467-71. PubMed ID: 6141286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R, Tschopp TB, Mittelholzer E, Baumgartner HR.
    J Pharmacol Exp Ther; 1985 Oct 12; 235(1):212-9. PubMed ID: 2995647
    [Abstract] [Full Text] [Related]

  • 16. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S, Shibata S, Kobayashi B.
    Thromb Haemost; 1978 Feb 28; 39(1):177-85. PubMed ID: 205972
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The increased sensitivity of platelets to prostacyclin in marathon runners.
    Dix CJ, Hassall DG, Bruckdorfer KR.
    Thromb Haemost; 1984 Jul 29; 51(3):385-7. PubMed ID: 6093280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.